Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)


Wir halten Sie auf dem Laufenden! Wenn Sie Fragen zu unseren Pressemitteilungen haben, können Sie uns gerne über das Kontaktformular der Website kontaktieren. Bleiben Sie über die neuesten Nachrichten unseres Unternehmens auf dem Laufenden:

Eckert & Ziegler BEBIG : Annual Report 2014 published

Seneffe - Belgium, March 26, 2015 - Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) announces today that its annual financial report for the year ending December 31, 2014 is now available on the company`s website:

Sales for 2014 were 28.8 million EUR, compared to 27.8 million EUR in 2013. Earnings per share were -0.17 EUR.

Financial Calendar 2015:
Annual General Meeting: June 11th, 2015 (11:30 am)
Half-Year Results 2015: August 4th, 2015

The results and trading updates will be published before market opens on the respective dates.


Eckert & Ziegler BEBIG
...Contributing to saving lives!

Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treatment of cancer using brachytherapy. The company headquarters are in Belgium, with production facilities in Germany and in the USA, as well as subsidiaries throughout Europe, the USA, India and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents, to support the international marketing and distribution of its product line.
The company's products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists.
Eckert & Ziegler BEBIG employs approximately 200 people. The company has been listed on the Euronext stock exchange since April 1997.

Contact :
Investor Relations
Tél.: +32 (0) 64 520 808